Compare EM & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EM | SENS |
|---|---|---|
| Founded | 2017 | 1996 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 296.7M | 301.2M |
| IPO Year | 2021 | 2014 |
| Metric | EM | SENS |
|---|---|---|
| Price | $1.20 | $6.82 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $1.25 | ★ $18.38 |
| AVG Volume (30 Days) | ★ 1.3M | 1.2M |
| Earning Date | 06-02-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,389,000.00 |
| Revenue This Year | $3.30 | $74.15 |
| Revenue Next Year | $5.26 | $58.60 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.85 |
| 52 Week Low | $1.01 | $0.41 |
| 52 Week High | $1.46 | $8.75 |
| Indicator | EM | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 66.07 | 61.22 |
| Support Level | $1.16 | $6.62 |
| Resistance Level | $1.42 | $6.87 |
| Average True Range (ATR) | 0.02 | 0.42 |
| MACD | 0.00 | 0.17 |
| Stochastic Oscillator | 73.68 | 100.00 |
Smart Share Global Ltd is a consumer tech company providing mobile device charging services through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Geographically, the company generates revenue from the PRC. The company has two segments, the mobile device charging segment and the PV business segment. The company generates the majority of its revenue from the mobile device charging segment.
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.